全文获取类型
收费全文 | 7129篇 |
免费 | 52篇 |
国内免费 | 79篇 |
专业分类
系统科学 | 141篇 |
丛书文集 | 210篇 |
教育与普及 | 384篇 |
理论与方法论 | 20篇 |
现状及发展 | 655篇 |
研究方法 | 902篇 |
综合类 | 4942篇 |
自然研究 | 6篇 |
出版年
2021年 | 8篇 |
2017年 | 13篇 |
2016年 | 12篇 |
2014年 | 23篇 |
2013年 | 22篇 |
2012年 | 468篇 |
2011年 | 554篇 |
2010年 | 158篇 |
2009年 | 100篇 |
2008年 | 605篇 |
2007年 | 567篇 |
2006年 | 593篇 |
2005年 | 653篇 |
2004年 | 457篇 |
2003年 | 416篇 |
2002年 | 374篇 |
2001年 | 258篇 |
2000年 | 395篇 |
1999年 | 141篇 |
1998年 | 50篇 |
1997年 | 25篇 |
1996年 | 28篇 |
1995年 | 16篇 |
1994年 | 22篇 |
1993年 | 19篇 |
1992年 | 22篇 |
1991年 | 29篇 |
1990年 | 27篇 |
1989年 | 49篇 |
1988年 | 32篇 |
1987年 | 33篇 |
1986年 | 35篇 |
1985年 | 33篇 |
1984年 | 42篇 |
1983年 | 25篇 |
1982年 | 39篇 |
1981年 | 33篇 |
1980年 | 20篇 |
1979年 | 23篇 |
1971年 | 21篇 |
1970年 | 41篇 |
1966年 | 18篇 |
1960年 | 11篇 |
1959年 | 79篇 |
1958年 | 168篇 |
1957年 | 95篇 |
1956年 | 103篇 |
1955年 | 97篇 |
1954年 | 98篇 |
1948年 | 40篇 |
排序方式: 共有7260条查询结果,搜索用时 15 毫秒
91.
92.
Mullighan CG Goorha S Radtke I Miller CB Coustan-Smith E Dalton JD Girtman K Mathew S Ma J Pounds SB Su X Pui CH Relling MV Evans WE Shurtleff SA Downing JR 《Nature》2007,446(7137):758-764
Chromosomal aberrations are a hallmark of acute lymphoblastic leukaemia (ALL) but alone fail to induce leukaemia. To identify cooperating oncogenic lesions, we performed a genome-wide analysis of leukaemic cells from 242 paediatric ALL patients using high-resolution, single-nucleotide polymorphism arrays and genomic DNA sequencing. Our analyses revealed deletion, amplification, point mutation and structural rearrangement in genes encoding principal regulators of B lymphocyte development and differentiation in 40% of B-progenitor ALL cases. The PAX5 gene was the most frequent target of somatic mutation, being altered in 31.7% of cases. The identified PAX5 mutations resulted in reduced levels of PAX5 protein or the generation of hypomorphic alleles. Deletions were also detected in TCF3 (also known as E2A), EBF1, LEF1, IKZF1 (IKAROS) and IKZF3 (AIOLOS). These findings suggest that direct disruption of pathways controlling B-cell development and differentiation contributes to B-progenitor ALL pathogenesis. Moreover, these data demonstrate the power of high-resolution, genome-wide approaches to identify new molecular lesions in cancer. 相似文献
93.
94.
95.
96.
97.
Escape from HER-family tyrosine kinase inhibitor therapy by the kinase-inactive HER3 总被引:1,自引:0,他引:1
Oncogenic tyrosine kinases have proved to be promising targets for the development of highly effective anticancer drugs. However, tyrosine kinase inhibitors (TKIs) against the human epidermal growth factor receptor (HER) family show only limited activity against HER2-driven breast cancers, despite effective inhibition of epidermal growth factor receptor (EGFR) and HER2 in vivo. The reasons for this are unclear. Signalling in trans is a key feature of this multimember family and the critically important phosphatidylinositol-3-OH kinase (PI(3)K)/Akt pathway is driven predominantly through transphosphorylation of the kinase-inactive HER3 (refs 9, 10). Here we show that HER3 and consequently PI(3)K/Akt signalling evade inhibition by current HER-family TKIs in vitro and in tumours in vivo. This is due to a compensatory shift in the HER3 phosphorylation-dephosphorylation equilibrium, driven by increased membrane HER3 expression driving the phosphorylation reaction and by reduced HER3 phosphatase activity impeding the dephosphorylation reaction. These compensatory changes are driven by Akt-mediated negative-feedback signalling. Although HER3 is not a direct target of TKIs, HER3 substrate resistance undermines their efficacy and has thus far gone undetected. The experimental abrogation of HER3 resistance by small interfering RNA knockdown restores potent pro-apoptotic activity to otherwise cytostatic HER TKIs, re-affirming the oncogene-addicted nature of HER2-driven tumours and the therapeutic promise of this oncoprotein target. However, because HER3 signalling is buffered against an incomplete inhibition of HER2 kinase, much more potent TKIs or combination strategies are required to silence oncogenic HER2 signalling effectively. The biologic marker with which to assess the efficacy of HER TKIs should be the transphosphorylation of HER3 rather than autophosphorylation. 相似文献
98.
Chinchilla D Zipfel C Robatzek S Kemmerling B Nürnberger T Jones JD Felix G Boller T 《Nature》2007,448(7152):497-500
Plants sense potential microbial invaders by using pattern-recognition receptors to recognize pathogen-associated molecular patterns (PAMPs). In Arabidopsis thaliana, the leucine-rich repeat receptor kinases flagellin-sensitive 2 (FLS2) (ref. 2) and elongation factor Tu receptor (EFR) (ref. 3) act as pattern-recognition receptors for the bacterial PAMPs flagellin and elongation factor Tu (EF-Tu) (ref. 5) and contribute to resistance against bacterial pathogens. Little is known about the molecular mechanisms that link receptor activation to intracellular signal transduction. Here we show that BAK1 (BRI1-associated receptor kinase 1), a leucine-rich repeat receptor-like kinase that has been reported to regulate the brassinosteroid receptor BRI1 (refs 6,7), is involved in signalling by FLS2 and EFR. Plants carrying bak1 mutations show normal flagellin binding but abnormal early and late flagellin-triggered responses, indicating that BAK1 acts as a positive regulator in signalling. The bak1-mutant plants also show a reduction in early, but not late, EF-Tu-triggered responses. The decrease in responses to PAMPs is not due to reduced sensitivity to brassinosteroids. We provide evidence that FLS2 and BAK1 form a complex in vivo, in a specific ligand-dependent manner, within the first minutes of stimulation with flagellin. Thus, BAK1 is not only associated with developmental regulation through the plant hormone receptor BRI1 (refs 6,7), but also has a functional role in PRR-dependent signalling, which initiates innate immunity. 相似文献
99.
Martinez Molina D Wetterholm A Kohl A McCarthy AA Niegowski D Ohlson E Hammarberg T Eshaghi S Haeggström JZ Nordlund P 《Nature》2007,448(7153):613-616
Cysteinyl leukotrienes are key mediators in inflammation and have an important role in acute and chronic inflammatory diseases of the cardiovascular and respiratory systems, in particular bronchial asthma. In the biosynthesis of cysteinyl leukotrienes, conversion of arachidonic acid forms the unstable epoxide leukotriene A4 (LTA4). This intermediate is conjugated with glutathione (GSH) to produce leukotriene C4 (LTC4) in a reaction catalysed by LTC4 synthase: this reaction is the key step in cysteinyl leukotriene formation. Here we present the crystal structure of the human LTC4 synthase in its apo and GSH-complexed forms to 2.00 and 2.15 A resolution, respectively. The structure reveals a homotrimer, where each monomer is composed of four transmembrane segments. The structure of the enzyme in complex with substrate reveals that the active site enforces a horseshoe-shaped conformation on GSH, and effectively positions the thiol group for activation by a nearby arginine at the membrane-enzyme interface. In addition, the structure provides a model for how the omega-end of the lipophilic co-substrate is pinned at one end of a hydrophobic cleft, providing a molecular 'ruler' to align the reactive epoxide at the thiol of glutathione. This provides new structural insights into the mechanism of LTC4 formation, and also suggests that the observed binding and activation of GSH might be common for a family of homologous proteins important for inflammatory and detoxification responses. 相似文献
100.